vs

Side-by-side financial comparison of Dexcom (DXCM) and XPO, Inc. (XPO). Click either name above to swap in a different company.

XPO, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.3B, roughly 1.7× Dexcom). Dexcom runs the higher net margin — 21.2% vs 4.8%, a 16.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 7.3%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 0.4%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

XPO, Inc., formerly XPO Logistics, is an American transportation company that conducts less-than-truckload shipping in North America. The company has headquarters in Greenwich, Connecticut, and has 592 locations globally. XPO is the second largest provider of less-than-truckload (LTL) services in North America, operating in 99 percent of all U.S. postal codes.

DXCM vs XPO — Head-to-Head

Bigger by revenue
XPO
XPO
1.7× larger
XPO
$2.1B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+14.3% gap
DXCM
21.6%
7.3%
XPO
Higher net margin
DXCM
DXCM
16.4% more per $
DXCM
21.2%
4.8%
XPO
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
0.4%
XPO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
XPO
XPO
Revenue
$1.3B
$2.1B
Net Profit
$267.3M
$101.0M
Gross Margin
62.9%
Operating Margin
25.6%
8.3%
Net Margin
21.2%
4.8%
Revenue YoY
21.6%
7.3%
Net Profit YoY
153.6%
46.4%
EPS (diluted)
$0.67
$0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
XPO
XPO
Q1 26
$1.3B
$2.1B
Q4 25
$1.3B
$2.0B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.0B
$2.0B
Q4 24
$1.1B
$1.9B
Q3 24
$994.2M
$2.1B
Q2 24
$1.0B
$2.1B
Net Profit
DXCM
DXCM
XPO
XPO
Q1 26
$267.3M
$101.0M
Q4 25
$267.3M
$59.0M
Q3 25
$283.8M
$82.0M
Q2 25
$179.8M
$106.0M
Q1 25
$105.4M
$69.0M
Q4 24
$151.7M
$75.0M
Q3 24
$134.6M
$95.0M
Q2 24
$143.5M
$150.0M
Gross Margin
DXCM
DXCM
XPO
XPO
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
XPO
XPO
Q1 26
25.6%
8.3%
Q4 25
25.6%
7.1%
Q3 25
20.1%
7.8%
Q2 25
18.4%
9.5%
Q1 25
12.9%
7.7%
Q4 24
17.0%
7.8%
Q3 24
15.3%
8.6%
Q2 24
15.7%
9.5%
Net Margin
DXCM
DXCM
XPO
XPO
Q1 26
21.2%
4.8%
Q4 25
21.2%
2.9%
Q3 25
23.5%
3.9%
Q2 25
15.5%
5.1%
Q1 25
10.2%
3.5%
Q4 24
13.6%
3.9%
Q3 24
13.5%
4.6%
Q2 24
14.3%
7.2%
EPS (diluted)
DXCM
DXCM
XPO
XPO
Q1 26
$0.67
$0.85
Q4 25
$0.67
$0.49
Q3 25
$0.70
$0.68
Q2 25
$0.45
$0.89
Q1 25
$0.27
$0.58
Q4 24
$0.37
$0.63
Q3 24
$0.34
$0.79
Q2 24
$0.35
$1.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
XPO
XPO
Cash + ST InvestmentsLiquidity on hand
$917.7M
$237.0M
Total DebtLower is stronger
$3.3B
Stockholders' EquityBook value
$2.7B
$1.9B
Total Assets
$6.3B
$8.2B
Debt / EquityLower = less leverage
1.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
XPO
XPO
Q1 26
$917.7M
$237.0M
Q4 25
$917.7M
$310.0M
Q3 25
$1.8B
$335.0M
Q2 25
$1.2B
$225.0M
Q1 25
$904.9M
$212.0M
Q4 24
$606.1M
$246.0M
Q3 24
$621.2M
$378.0M
Q2 24
$939.2M
$250.0M
Total Debt
DXCM
DXCM
XPO
XPO
Q1 26
$3.3B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
XPO
XPO
Q1 26
$2.7B
$1.9B
Q4 25
$2.7B
$1.9B
Q3 25
$2.7B
$1.8B
Q2 25
$2.6B
$1.8B
Q1 25
$2.3B
$1.6B
Q4 24
$2.1B
$1.6B
Q3 24
$2.0B
$1.6B
Q2 24
$2.4B
$1.5B
Total Assets
DXCM
DXCM
XPO
XPO
Q1 26
$6.3B
$8.2B
Q4 25
$6.3B
$8.2B
Q3 25
$7.5B
$8.2B
Q2 25
$7.3B
$8.1B
Q1 25
$6.8B
$7.9B
Q4 24
$6.5B
$7.7B
Q3 24
$6.4B
$7.9B
Q2 24
$6.8B
$7.7B
Debt / Equity
DXCM
DXCM
XPO
XPO
Q1 26
1.77×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
XPO
XPO
Operating Cash FlowLast quarter
$183.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.81×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
XPO
XPO
Q1 26
$183.0M
Q4 25
$294.0M
Q3 25
$659.9M
$371.0M
Q2 25
$303.0M
$247.0M
Q1 25
$183.8M
$142.0M
Q4 24
$301.4M
$189.0M
Q3 24
$199.5M
$264.0M
Q2 24
$279.4M
$210.0M
Free Cash Flow
DXCM
DXCM
XPO
XPO
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
$215.0M
Q2 25
$208.9M
$51.0M
Q1 25
$96.8M
$-57.0M
Q4 24
$176.8M
$23.0M
Q3 24
$88.3M
$137.0M
Q2 24
$213.3M
$20.0M
FCF Margin
DXCM
DXCM
XPO
XPO
Q1 26
Q4 25
15.3%
Q3 25
47.9%
10.2%
Q2 25
18.1%
2.5%
Q1 25
9.3%
-2.9%
Q4 24
15.9%
1.2%
Q3 24
8.9%
6.7%
Q2 24
21.2%
1.0%
Capex Intensity
DXCM
DXCM
XPO
XPO
Q1 26
Q4 25
8.1%
5.3%
Q3 25
6.7%
7.4%
Q2 25
8.1%
9.4%
Q1 25
8.4%
10.2%
Q4 24
11.2%
8.6%
Q3 24
11.2%
6.2%
Q2 24
6.6%
9.1%
Cash Conversion
DXCM
DXCM
XPO
XPO
Q1 26
1.81×
Q4 25
1.10×
Q3 25
2.33×
4.52×
Q2 25
1.69×
2.33×
Q1 25
1.74×
2.06×
Q4 24
1.99×
2.52×
Q3 24
1.48×
2.78×
Q2 24
1.95×
1.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons